Etisalat, GSMA join diabetes battle
Abu Dhabi, June 25, 2013
The Etisalat Group and the GSM Association are working together in the battle against diabetes in a multinational effort to bring the latest mHealth technologies to the Middle East, Africa and Asia.
Etisalat is the sponsor of the GSMA Ministerial Summit on diabetes which is scheduled to take place in Dubai in November and is also working with the global ICT community to test and build research data to prove the impact mobile technologies can have on the disease and other conditions.
During a meeting at the company’s head office in Abu Dhabi, Michael Curran from the GSMA’s mHealth team met with Etisalat Group’s chief digital services officer, Khalifa Al Shamsi to discuss the innovations and roadmap for mHealth across the company’s footprint of 15 countries.
Al Shamsi said: “Diabetes is a disease that is limiting the potential of millions of people across the Middle East, Africa and Asia. What is worrying is that this condition is now affecting more and more younger people and children. Mobile technology is part of the solution and can significantly contribute to improving living conditions of all. We are delighted to play our part in working with our global partners in this endeavor.”
Curran also met with Abdulaziz Al Sawaleh, the Etisalat Group’s chief human resources officer, who has led a campaign to recruit volunteers from across Etisalat’s operations to participate in the GSMA mHealth Grand Tour. This is a 2,000 km cycle ride from Brussels to Barcelona where each rider will be equipped with the latest technology geared at managing diabetes.
Curran said: “Diabetes and other health conditions are global issues and no individual organization can make a significant impact working alone. The GSMA through its Mobile for Development program is coordinating efforts across the industry for the betterment of all. We thank Etisalat and the other ICT companies who are participating in our events for their significant contribution and leadership in the fight against diabetes.” – TradeArabia News Service